Orphenadrine citrate
ADVERTISEMENT
- Molecular formula
- C24H31NO3
- CAS Number
- 83-98-7
- IUPAC Name
- (1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenyl-acetate
- Molecular Weight
- 461.52g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.1273g/cm3
- Synonyms
- mepenzolate
Identification
Interesting facts
Interesting Facts about (1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenyl-acetate
(1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenyl-acetate is a fascinating compound with significant implications in various fields of chemistry and biochemistry. Below are some engaging insights into this unique chemical:
- Structure and Stability: The presence of a piperidine ring gives this compound its unique chemical stability and reactivity. The quaternary ammonium ion enhances its solubility in polar solvents, which is advantageous for applications in drug formulation.
- Biological Importance: Derivatives of piperidine are often studied for their potential therapeutic effects. This compound could potentially influence biological pathways, making it a subject of interest in medicinal chemistry.
- Pharmacological Applications: Compounds like this one may act as ligands for neurotransmitter receptors or influence enzyme activity, showcasing their potential use in neuropharmacology.
- Synthetic Versatility: The synthesis of this compound may involve innovative organic reactions, such as N-alkylation and esterification. Its complex structure serves as a scaffold for developing novel compounds in chemical research.
- Research Potential: Ongoing studies could unveil new insights into its interaction mechanisms, particularly in the context of drug discovery and development.
In conclusion, the study of (1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenyl-acetate not only deepens our understanding of piperidine derivatives but also opens new avenues in the fields of pharmacology and medicinal chemistry. As scientists continue to explore its properties, this compound holds promise for future advancements in therapeutic agents.